LifeMD, Inc. (LFMD)
LFMD Stock Price Chart
Explore LifeMD, Inc. interactive price chart. Choose custom timeframes to analyze LFMD price movements and trends.
LFMD Company Profile
Discover essential business fundamentals and corporate details for LifeMD, Inc. (LFMD) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
29 Jan 2008
Employees
304.00
Website
https://www.lifemd.comCEO
Justin Schreiber
Description
LifeMD, Inc. operates as a leading digital health company, specializing in direct-to-consumer telemedicine across the United States. The firm links individuals with licensed medical professionals to address a diverse spectrum of health concerns, including concierge services, men's sexual health, dermatological conditions, and more. Under its umbrella, LifeMD manages several specialized virtual care platforms: ShapiroMD is a telehealth brand focused on hair restoration, delivering virtual consultations, prescription medications, patented over-the-counter formulations, an FDA-cleared medical device, and custom-compounded topical treatments for both male and female hair loss. RexMD serves as a men's telehealth brand, providing virtual medical treatment from licensed providers for a wide array of male-specific health needs. LifeMD Primary Care offers a personalized, subscription-based virtual primary care solution, addressing routine, urgent, and chronic health management requirements. This mobile-centric platform integrates remote consultations, medication management, diagnostic services, and imaging referrals. Cleared is a telehealth service dedicated to offering personalized therapies for allergic, asthmatic, and immunological conditions. Nava MD stands as a skincare and tele-dermatology brand catering specifically to women, facilitating virtual access to dermatologists and other specialists for medical treatment. Additionally, the company provides PDFSimpli, a cloud-based software-as-a-service (SaaS) platform that empowers users to create, edit, convert, sign, and share PDF documents online. LifeMD distributes its offerings directly to individuals, via its own e-commerce channels, and through collaborations with external partners. Originally established in 1994 as Conversion Labs, Inc., the company rebranded to LifeMD, Inc. in February 2021 and is headquartered in New York City.
LFMD Financial Timeline
Browse a chronological timeline of LifeMD, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Aug 2026
EPS estimate is -$0.15, while revenue estimate is $49.15m.
Earnings released on 6 May 2026
EPS came in at -$0.20 falling short of the estimated -$0.14 by -42.86%, while revenue for the quarter reached $50.16m , beating expectations by +2.71%.
Earnings released on 9 Mar 2026
EPS came in at -$0.04 falling short of the estimated -$0.01 by -300.00%, while revenue for the quarter reached $46.87m , beating expectations by +2.28%.
Earnings released on 17 Nov 2025
EPS came in at -$0.10 falling short of the estimated -$0.06 by -66.67%, while revenue for the quarter reached $60.17m , beating expectations by +23.88%.
Earnings released on 4 Aug 2025
EPS came in at -$0.05 falling short of the estimated $0.18 by -125.96%, while revenue for the quarter reached $62.22m , missing expectations by -6.18%.
Earnings released on 6 May 2025
EPS came in at $0.01 surpassing the estimated -$0.04 by +125.00%, while revenue for the quarter reached $65.70m , beating expectations by +0.36%.
Earnings released on 10 Mar 2025
EPS came in at -$0.02 surpassing the estimated -$0.04 by +50.00%, while revenue for the quarter reached $64.25m , beating expectations by +7.77%.
Earnings released on 7 Nov 2024
EPS came in at -$0.14 falling short of the estimated -$0.12 by -16.67%, while revenue for the quarter reached $53.27m , missing expectations by -7.69%.
Earnings released on 7 Aug 2024
EPS came in at -$0.19 falling short of the estimated -$0.12 by -58.33%, while revenue for the quarter reached $50.66m , beating expectations by +5.00%.
Earnings released on 8 May 2024
EPS came in at -$0.19 falling short of the estimated -$0.15 by -26.67%, while revenue for the quarter reached $44.14m , beating expectations by +3.77%.
Earnings released on 11 Mar 2024
EPS came in at -$0.12 surpassing the estimated -$0.14 by +14.29%, while revenue for the quarter reached $44.86m , beating expectations by +10.79%.
Earnings released on 8 Nov 2023
EPS came in at -$0.20 falling short of the estimated -$0.15 by -33.33%, while revenue for the quarter reached $38.61m , missing expectations by -4.63%.
Earnings released on 9 Aug 2023
EPS came in at -$0.23 falling short of the estimated -$0.10 by -130.00%, while revenue for the quarter reached $35.95m , beating expectations by +2.24%.
Earnings released on 12 May 2023
EPS came in at -$0.15 surpassing the estimated -$0.16 by +6.25%, while revenue for the quarter reached $33.13m , beating expectations by +7.55%.
Earnings released on 22 Mar 2023
EPS came in at $0.02 surpassing the estimated -$0.18 by +111.11%, while revenue for the quarter reached $28.12m , missing expectations by -16.31%.
Earnings released on 10 Nov 2022
EPS came in at -$0.03 surpassing the estimated -$0.27 by +88.89%, while revenue for the quarter reached $31.41m , missing expectations by -1.36%.
Earnings released on 11 Aug 2022
EPS came in at -$0.22 surpassing the estimated -$0.23 by +4.35%, while revenue for the quarter reached $30.46m , missing expectations by -2.73%.
Earnings released on 13 May 2022
EPS came in at -$0.25 surpassing the estimated -$0.26 by +3.85%, while revenue for the quarter reached $29.04m , missing expectations by -7.88%.
Earnings released on 7 Mar 2022
EPS came in at -$0.29 surpassing the estimated -$0.39 by +25.64%, while revenue for the quarter reached $27.42m , missing expectations by -0.16%.
Earnings released on 10 Nov 2021
EPS came in at -$0.36 surpassing the estimated -$0.49 by +26.53%, while revenue for the quarter reached $24.95m , missing expectations by -20.97%.
Earnings released on 12 Aug 2021
EPS came in at -$0.64 falling short of the estimated -$0.53 by -20.75%, while revenue for the quarter reached $22.31m , beating expectations by +1.98%.
LFMD Stock Performance
Access detailed LFMD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
